# TumorBoard v1
An LLM-powered cancer variant actionability assessment tool with a built-in validation framework.

**TL;DR**:
Molecular tumor boards manually review cancer variants to assign clinical actionabilityâ€”a time-consuming process  
requiring expert panels. This research tool automates that workflow by fetching variant evidence from genomic databases   
(CIViC, ClinVar, COSMIC) and using LLMs to assign AMP/ASCO/CAP tier classifications, mimicking expert judgment.   
Includes a validation framework to benchmark LLM accuracy against gold-standard classifications.  
This is a research prototype exploring whether LLMs can approximate clinical decision-making; not for actual clinical use.

## ðŸŒ Web Application Available!

**NEW**: TumorBoard now includes a modern web interface built with Angular and Flask!

- **Interactive UI**: User-friendly form for variant assessment
- **Real-time Results**: See comprehensive annotations and LLM analysis
- **REST API**: Flask backend with async support
- **Modern Stack**: Angular 17 + Flask with CORS enabled
- **ðŸ³ Docker Ready**: One-command deployment with Docker Compose

### Quick Start with Docker

```bash
# 1. Set your API key
echo "OPENAI_API_KEY=your-key" > .env

# 2. Start everything
docker compose up -d

# 3. Open in browser
open http://localhost
```

**Access:**
- **Frontend**: http://localhost
- **Backend API**: http://localhost:5000

ðŸ‘‰ **[Docker Guide](DOCKER.md)** | **[Web Application Details](README_WEBAPP.md)**

## Overview

TumorBoard combines clinical evidence from multiple genomic databases (CIViC, ClinVar, COSMIC). It then uses large language models to approximate expert application of the **AMP/ASCO/CAP 4-tier classification system**.

Available as both:
- **Web Application**: Angular frontend + Flask REST API
- **Command-Line Interface**: Python CLI tool

### Key Features

- **Evidence Aggregation**: Automatically fetches variant evidence from MyVariant.info API
- **Database Identifiers**: Extracts COSMIC, dbSNP, ClinVar, NCBI Gene IDs, and HGVS notations
- **Functional Annotations**: SnpEff effects, PolyPhen2 predictions, CADD scores, gnomAD frequencies
- **LLM Assessment**: Uses LLMs to interpret evidence and assign actionability tiers
- **Validation Framework**: Benchmarks against gold standard datasets
- **Multiple LLM Support**: Works with OpenAI, Anthropic, and other providers via litellm
- **Async Throughout**: Fast, concurrent processing for batch assessments
- **Rich CLI**: Command-line interface with progress indicators
- **Web Interface**: Modern Angular application with REST API backend

## Why This Tool Exists

Molecular tumor boards face significant challenges:

1. **Resource Intensive**: Expert panels must manually review variants and apply 
   classification frameworks - a time-consuming process requiring coordinated expertise.
2. **Coverage Gaps**: Curated databases like CIViC don't cover every variant-tumor 
   combination, especially rare or novel variants.
3. **Evidence Fragmentation**: Relevant evidence is scattered across multiple 
   databases (CIViC, ClinVar, COSMIC), requiring manual synthesis.
4. **Rapid Evolution**: New trials and approvals constantly change variant 
   actionability.

## Disclaimer

**Limitations:**
- LLMs may hallucinate or misinterpret evidence 
- Pattern matching â‰  expert clinical judgment  
- Requires validation against gold standards (hence the built-in framework)
- Evidence quality: Depends on database coverage
- Novel variants: Limited data for rare variants
- Context windows: Very long evidence may be truncated

**This tool is for research purposes only.** Clinical decisions should always 
be made by qualified healthcare professionals.

## Getting Started

### Pick Your Interface

**Option 1: Web Application (Docker - No Install Required)**

Use the web interface with zero local setup:

```bash
# 1. Set API key
echo "OPENAI_API_KEY=your-key" > .env

# 2. Start
docker compose up -d

# 3. Open http://localhost
```

**That's it!** No pip install, no dependencies. Docker handles everything.

---

**Option 2: CLI Tool (Requires pip install)**

Use the command-line interface for batch processing and validation:

```bash
# 1. Clone and install
git clone <repository-url>
cd tumor_board_v0
pip install -e .

# 2. Set API key
export OPENAI_API_KEY="your-key-here"

# 3. Use CLI commands
tumorboard assess BRAF V600E --tumor "Melanoma"
tumorboard batch benchmarks/sample_batch.json
tumorboard validate benchmarks/gold_standard.json
```

**Alternative Models:**
```bash
# Use Anthropic Claude
export ANTHROPIC_API_KEY="your-key-here"
tumorboard assess BRAF V600E --model claude-3-sonnet-20240229
```

## CLI Reference

### `assess` - Single Variant
Specify a single variant, then run this command to fetch variant evidence and use the LLM to assign an AMP/ASCO/CAP tier classification.

```bash
tumorboard assess <GENE> <VARIANT> [OPTIONS]

Options:
  -t, --tumor TEXT         Tumor type (optional, e.g., "Melanoma")
  -m, --model TEXT         LLM model [default: gpt-4o-mini]
  --temperature FLOAT      LLM temperature (0.0-1.0) [default: 0.1]
  -o, --output PATH        Save to JSON file
```

Example output:
```
Assessing BRAF V600E in Melanoma...

Variant: BRAF V600E | Tumor: Melanoma
Tier: Tier I | Confidence: 95.0%
Identifiers: COSMIC: COSM476 | NCBI Gene: 673 | dbSNP: rs113488022 | ClinVar: 13961
HGVS: Genomic: chr7:g.140453136A>T
ClinVar: Significance: Pathogenic | Accession: RCV000013961
Annotations: Effect: missense_variant | PolyPhen2: D | CADD: 32.00 | gnomAD AF: 0.000004
Transcript: ID: NM_004333.4 | Consequence: missense_variant

BRAF V600E is a well-established actionable mutation in melanoma...

Therapies: Vemurafenib, Dabrafenib
```

**Note**: Database identifiers, functional annotations, and transcript information are automatically extracted from MyVariant.info when available and displayed in both console output and JSON files.

### `batch` - Multiple Variants
Specify a JSON file with variant details (gene, variant, tumor type), then run this command to process them concurrently and generate batch results.

```bash
tumorboard batch <INPUT_FILE> [OPTIONS]

Options:
  -o, --output PATH        Output file [default: results.json]
  -m, --model TEXT         LLM model [default: gpt-4o-mini]
  --temperature FLOAT      LLM temperature (0.0-1.0) [default: 0.1]
```

Input format: `[{"gene": "BRAF", "variant": "V600E", "tumor_type": "Melanoma"}, ...]`

### `validate` - Test Accuracy
Specify a gold standard dataset with known correct tier classifications, then run this command to benchmark the LLM's performance and identify where it agrees or disagrees with expert consensusâ€”this is critical for evaluating reliability before using the tool for research.

Provides:
- Overall accuracy and per-tier precision/recall/F1
- Failure analysis showing where and why mistakes occur
- Tier distance metrics

```bash
tumorboard validate <GOLD_STANDARD_FILE> [OPTIONS]

Options:
  -m, --model TEXT         LLM model [default: gpt-4o-mini]
  --temperature FLOAT      LLM temperature (0.0-1.0) [default: 0.1]
  -o, --output PATH        Save detailed results
  -c, --max-concurrent N   Concurrent validations [default: 3]
```

Gold standard format: `{"entries": [{"gene": "BRAF", "variant": "V600E", "tumor_type": "Melanoma", "expected_tier": "Tier I", ...}]}`

## AMP/ASCO/CAP Tier System

- **Tier I**: Variants with strong clinical significance
  - FDA-approved therapies for specific variant + tumor type
  - Professional guideline recommendations
  - Strong evidence from clinical trials

- **Tier II**: Variants with potential clinical significance
  - FDA-approved therapies for different tumor types
  - Clinical trial evidence
  - Case reports or smaller studies

- **Tier III**: Variants of unknown clinical significance
  - Preclinical evidence only
  - Uncertain biological significance
  - Conflicting evidence

- **Tier IV**: Benign or likely benign variants
  - Known benign polymorphisms
  - No oncogenic evidence


## Variant Annotations

TumorBoard automatically extracts comprehensive variant annotations from MyVariant.info:

### Database Identifiers
- **COSMIC ID**: Catalogue of Somatic Mutations in Cancer identifier (e.g., COSM476)
- **NCBI Gene ID**: Entrez Gene identifier (e.g., 673 for BRAF)
- **dbSNP ID**: Reference SNP identifier (e.g., rs113488022)
- **ClinVar ID**: ClinVar variation identifier (e.g., 13961)
- **ClinVar Clinical Significance**: Pathogenicity classification (e.g., Pathogenic, Benign)
- **ClinVar Accession**: ClinVar record accession (e.g., RCV000013961)

### HGVS Notations
- **Genomic**: Chromosome-level notation (e.g., chr7:g.140453136A>T)
- **Protein**: Amino acid change notation (when available)
- **Transcript**: cDNA-level notation (when available)

### Functional Annotations
- **SnpEff Effect**: Predicted variant effect (e.g., missense_variant, stop_gained)
- **PolyPhen2**: Pathogenicity prediction (D=Damaging, P=Possibly damaging, B=Benign)
- **CADD Score**: Combined Annotation Dependent Depletion score (higher = more deleterious)
- **gnomAD AF**: Population allele frequency from gnomAD exomes (helps assess rarity)

### Transcript Information
- **Transcript ID**: Reference transcript identifier (e.g., NM_004333.4)
- **Consequence**: Effect on transcript (e.g., missense_variant, frameshift_variant)

All annotations are included in:
- Console output (via the assessment report)
- JSON output files (when using `--output` flag)
- Batch processing results

**Note**: Annotation availability depends on database coverage. Not all variants have complete annotation in all databases.

## Configuration

**Supported Models:** OpenAI (gpt-4, gpt-4o, gpt-4o-mini), Anthropic (claude-3 series), Google (gemini), Azure OpenAI

**Data Sources:** MyVariant.info aggregates CIViC, ClinVar, and COSMIC databases

**Performance:** GPT-4 is more accurate but expensive; gpt-4o-mini offers good balance.


## Contributing

See [CONTRIBUTING.md](CONTRIBUTING.md) for development setup, testing, and code quality guidelines.

## License & Citation

**Author:** Dami Gupta (dami.gupta@gmail.com)

**License:** MIT License

**Citation:** If you use TumorBoard in your research, please cite:

```bibtex
@software{tumorboard2025,
  author = {Gupta, Dami},
  title = {TumorBoard: LLM-Powered Cancer Variant Actionability Assessment},
  year = {2025},
  url = {https://github.com/dami-gupta-git/tumor_board_v0}
}
```

## References

- [AMP/ASCO/CAP Guidelines](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707196/)
- [MyVariant.info](https://myvariant.info/) | [CIViC](https://civicdb.org/) | [ClinVar](https://www.ncbi.nlm.nih.gov/clinvar/) | [COSMIC](https://cancer.sanger.ac.uk/cosmic)

---

**Note**: This tool is for research purposes only. Clinical decisions should always be made by qualified healthcare professionals.
